![\"\"](\"https:\/\/thelehighacresgazette.com\/news\/wp-content\/uploads\/2021\/10\/JJ-vaccine.jpg\")
<\/figure><\/div>\n\n\n\nDuring a Pharmacovigilance Risk Assessment Committee meeting,<\/a> the agency said it found a possible link between venous thromboembolism (VTE) and the J&J vaccine. <\/p>\n\n\n\n “VTE is a condition in which a blood clot forms in a deep vein, usually in a leg, arm or groin, and may travel to the lungs causing a blockage of the blood supply, with possible life-threatening consequences,” the agency wrote in its meeting highlights.<\/p>\n\n\n\n It is recommending that the condition be listed as a rare side effect.<\/p>\n\n\n\n The agency also recommends that immune thrombocytopenia (ITP) be listed as a side effect of the J&J vaccine and AstraZeneca’s vaccine.<\/p>\n\n\n\n ITP is a bleeding disorder in which “the immune system mistakenly targets blood cells called platelets that are needed for normal blood clotting,” the agency wrote.<\/p>\n\n\n\n While J&J said the conditions are rare, it will update the product information and continue to work closely with EMA and other government agencies, according to Reuters.<\/a><\/p>\n\n\n\n “We strongly support raising awareness of the signs and symptoms of rare events to ensure they can be quickly identified and effectively treated,” the company said in a July statement<\/a>.<\/p>\n\n\n\n